Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Still More About Secondary Cancer Risk From Using Revlimd At www.HelpWithCancer.org

Home/Still More About Secondary Cancer Risk From Using Revlimd At www.HelpWithCancer.org

Still More About Secondary Cancer Risk From Using Revlimd At www.HelpWithCancer.org

I wrote more about the new, secondary cancer risk revelations connected with Revlimid in an article on our other daily, cancer related site, http://www.helpwithcancer.org/. yesterday: 

Two Examples Of Drugs With An 8% Risk Of Causing Secondary Cancers Revealed Yesterday: Avista & Revlimid.

The article focuses on the strange but true coincidence of two unrelated and FDA proved drugs–Avista, an osteoporosis drug, and Revlimid, an oral chemotherapy–both being “outed,” based on data revealed from two different sources in two different places, all on the same day.  It turns out that long term use of either drug results in an 8% chance of the user developing a secondary cancer.
 
Feel good and keep smiling!  Pat